Article Details

Xeris Pharmaceuticals to acquire Strongbridge Biopharma for $267m

Retrieved on: 2021-05-25 08:36:19

Tags for this article:

Click the tags to see associated articles and topics

Xeris Pharmaceuticals to acquire Strongbridge Biopharma for $267m. View article details on hiswai:

Excerpt

After acquisition, Xeris and Strongbridge businesses will operate together under Xeris Biopharma. Credit: Gerd Altmann from Pixabay. Subscribe to our ...

Article found on: pharmaceutical-business-review.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up